"Serum GFAP and NfL Levels Differentiate Subsequent Progression and Disease Activity in Patients With Progressive Multiple Sclerosis." Neurology - Neuroimmunology Neuroinflammation
10.1
(2023):
e200052.
Web. 04 Feb. 2023.
Advertisement